xospata
astellas pharma europe b.v. - gilteritinib fumarate - leukemija, mieloidas, ūmus - antinavikiniai vaistai - xospata yra nurodyta kaip monotherapy gydyti suaugusiems pacientams, kurie turi atsinaujino arba ugniai atsparios ūminės mieloidinės leukemijos (ppp) su flt3 mutacijos.
padcev
astellas pharma europe b.v. - enfortumab vedotin - carcinoma, transitional cell; urologic neoplasms - antinavikiniai vaistai - padcev as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and a programmed death receptor 1 or programmed death ligand 1 inhibitor.
meropenem venus pharma
venus pharma gmbh - meropenemas - milteliai injekciniam ar infuziniam tirpalui - 500 mg - meropenem
meropenem venus pharma
venus pharma gmbh - meropenemas - milteliai injekciniam ar infuziniam tirpalui - 1000 mg - meropenem
dasatinib accordpharma
accord healthcare s.l.u. - dasatinibas - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antinavikiniai vaistai - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
ivabradine ingen pharma
sia ingen pharma - ivabradinas - plėvele dengtos tabletės - 7,5 mg - ivabradine
pantoprazole ingen pharma
sia ingen pharma - pantoprazolas - skrandyje neirios tabletės - 20 mg; 40 mg - pantoprazole
olopatadine unimed pharma
unimed pharma spol. s r.o. - olopatadinas - akių lašai (tirpalas) - 1 mg/ml - olopatadine
bendamustine hydrochloride boston biopharma
boston biopharma lt, uab - bendamustino hidrochloridas - milteliai infuzinio tirpalo koncentratui - 2,5 mg/ml - bendamustine
trimetazidine ingen pharma
sia ingen pharma - trimetazidino hidrochloridas - pailginto atpalaidavimo tabletės - 35 mg - trimetazidine